Similar articles for PMID: 11395243

Year	Number of Results
1986	2
1987	1
1988	4
1989	1
1990	2
1991	5
1992	3
1993	5
1994	5
1995	10
1996	3
1997	9
1998	9
1999	6
2000	6
2001	16
2002	9
2003	5
2004	3
2005	4
2006	2
2007	3
2008	3
2009	4
2010	3
2011	1
2012	1
2013	2
2014	2
2015	5
2016	3
2017	1
2019	1
2020	1
2022	1
2023	2
2024	0

1

Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.

Wilder RB, Rodriguez MA, Tucker SL, Ha CS, Hess MA, Cabanillas FF, Cox JD. Wilder RB, et al. Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):743-9. doi: 10.1016/s0360-3016(01)01503-6. Int J Radiat Oncol Biol Phys. 2001. PMID: 11395243 Clinical Trial.

2

Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.

Schlembach PJ, Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD. Schlembach PJ, et al. Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1107-10. doi: 10.1016/s0360-3016(00)00760-4. Int J Radiat Oncol Biol Phys. 2000. PMID: 11072169

3

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB. Hagemeister FB. Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review.

4

Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.

Cabanillas F, Rodriguez-Diaz Pavón J, Hagemeister FB, McLaughlin P, Rodriguez MA, Romaguera JE, Dong K, Moon T. Cabanillas F, et al. Ann Oncol. 1998 May;9(5):511-8. doi: 10.1023/a:1008214629544. Ann Oncol. 1998. PMID: 9653492 Free article. Clinical Trial.

5

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.

Rodriguez MA, Cabanillas FC, Velasquez W, Hagemeister FB, McLaughlin P, Swan F, Romaguera JE. Rodriguez MA, et al. J Clin Oncol. 1995 Jul;13(7):1734-41. doi: 10.1200/JCO.1995.13.7.1734. J Clin Oncol. 1995. PMID: 7602363

6

Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma.

Intragumtornchai T, Bunworasate U, Nakorn TN, Rojnuckarin P. Intragumtornchai T, et al. Leuk Lymphoma. 2006 Jul;47(7):1306-14. doi: 10.1080/10428190500525656. Leuk Lymphoma. 2006. PMID: 16923561 Clinical Trial.

7

A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.

Romaguera JE, Rodriguez MA, Hagemeister FB, McLaughlin P, Swan F, Moore DF Jr, Sarris AH, Younes A, Hill D, Cabanillas F. Romaguera JE, et al. Invest New Drugs. 1994;12(3):217-22. doi: 10.1007/BF00873962. Invest New Drugs. 1994. PMID: 7896540 Clinical Trial.

8

Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.

Dincol D, Buyukcelik A, Dogan M, Akbulut H, Samur M, Demirkazik A, Senler FC, Onur H, Icli F. Dincol D, et al. Med Oncol. 2010 Sep;27(3):942-5. doi: 10.1007/s12032-009-9313-x. Epub 2009 Sep 29. Med Oncol. 2010. PMID: 19787462 Clinical Trial.

9

Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.

Krol AD, Berenschot HW, Doekharan D, Henzen-Logmans S, van der Holt B, van 't Veer MB. Krol AD, et al. Radiother Oncol. 2001 Mar;58(3):251-5. doi: 10.1016/s0167-8140(00)00272-3. Radiother Oncol. 2001. PMID: 11230885

10

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD. Wilder RB, et al. Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):17-22. doi: 10.1016/s0360-3016(00)01383-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11163493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

137 results

Results by year